Ying Shen1, Mumtahena Rahman1, Stephen R Piccolo2, Daniel Gusenleitner1, Nader N El-Chaar1, Luis Cheng1, Stefano Monti1, Andrea H Bild2, W Evan Johnson2. 1. Division of Computational Biomedicine, Boston University School of Medicine, Boston, MA 02118 USA, Department of Biomedical Informatics and Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112 USA. 2. Division of Computational Biomedicine, Boston University School of Medicine, Boston, MA 02118 USA, Department of Biomedical Informatics and Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112 USA Division of Computational Biomedicine, Boston University School of Medicine, Boston, MA 02118 USA, Department of Biomedical Informatics and Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112 USA.
Abstract
MOTIVATION: Although gene-expression signature-based biomarkers are often developed for clinical diagnosis, many promising signatures fail to replicate during validation. One major challenge is that biological samples used to generate and validate the signature are often from heterogeneous biological contexts-controlled or in vitro samples may be used to generate the signature, but patient samples may be used for validation. In addition, systematic technical biases from multiple genome-profiling platforms often mask true biological variation. Addressing such challenges will enable us to better elucidate disease mechanisms and provide improved guidance for personalized therapeutics. RESULTS: Here, we present a pathway profiling toolkit, Adaptive Signature Selection and InteGratioN (ASSIGN), which enables robust and context-specific pathway analyses by efficiently capturing pathway activity in heterogeneous sets of samples and across profiling technologies. The ASSIGN framework is based on a flexible Bayesian factor analysis approach that allows for simultaneous profiling of multiple correlated pathways and for the adaptation of pathway signatures into specific disease. We demonstrate the robustness and versatility of ASSIGN in estimating pathway activity in simulated data, cell lines perturbed pathways and in primary tissues samples including The Cancer Genome Atlas breast carcinoma samples and liver samples exposed to genotoxic carcinogens. AVAILABILITY AND IMPLEMENTATION: Software for our approach is available for download at: http://www.bioconductor.org/packages/release/bioc/html/ASSIGN.html and https://github.com/wevanjohnson/ASSIGN.
MOTIVATION: Although gene-expression signature-based biomarkers are often developed for clinical diagnosis, many promising signatures fail to replicate during validation. One major challenge is that biological samples used to generate and validate the signature are often from heterogeneous biological contexts-controlled or in vitro samples may be used to generate the signature, but patient samples may be used for validation. In addition, systematic technical biases from multiple genome-profiling platforms often mask true biological variation. Addressing such challenges will enable us to better elucidate disease mechanisms and provide improved guidance for personalized therapeutics. RESULTS: Here, we present a pathway profiling toolkit, Adaptive Signature Selection and InteGratioN (ASSIGN), which enables robust and context-specific pathway analyses by efficiently capturing pathway activity in heterogeneous sets of samples and across profiling technologies. The ASSIGN framework is based on a flexible Bayesian factor analysis approach that allows for simultaneous profiling of multiple correlated pathways and for the adaptation of pathway signatures into specific disease. We demonstrate the robustness and versatility of ASSIGN in estimating pathway activity in simulated data, cell lines perturbed pathways and in primary tissues samples including The Cancer Genome Atlas breast carcinoma samples and liver samples exposed to genotoxic carcinogens. AVAILABILITY AND IMPLEMENTATION: Software for our approach is available for download at: http://www.bioconductor.org/packages/release/bioc/html/ASSIGN.html and https://github.com/wevanjohnson/ASSIGN.
Authors: Brigitte Ganter; Stuart Tugendreich; Cecelia I Pearson; Eser Ayanoglu; Susanne Baumhueter; Keith A Bostian; Lindsay Brady; Leslie J Browne; John T Calvin; Gwo-Jen Day; Naiomi Breckenridge; Shane Dunlea; Barrett P Eynon; L Mike Furness; Joe Ferng; Mark R Fielden; Susan Y Fujimoto; Li Gong; Christopher Hu; Radha Idury; Michael S B Judo; Kyle L Kolaja; May D Lee; Christopher McSorley; James M Minor; Ramesh V Nair; Georges Natsoulis; Peter Nguyen; Simone M Nicholson; Hang Pham; Alan H Roter; Dongxu Sun; Siqi Tan; Silke Thode; Alexander M Tolley; Antoaneta Vladimirova; Jian Yang; Zhiming Zhou; Kurt Jarnagin Journal: J Biotechnol Date: 2005-09-29 Impact factor: 3.307
Authors: Stephen R Piccolo; Michelle R Withers; Owen E Francis; Andrea H Bild; W Evan Johnson Journal: Proc Natl Acad Sci U S A Date: 2013-10-15 Impact factor: 11.205
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: Gajendra Shrestha; Shelley M MacNeil; Jasmine A McQuerry; David F Jenkins; Sunil Sharma; Andrea H Bild Journal: Semin Cell Dev Biol Date: 2016-06-20 Impact factor: 7.727
Authors: Kevin Brown Chandler; Khalid A Alamoud; Vanessa L Stahl; Bach-Cuc Nguyen; Vinay K Kartha; Manish V Bais; Kenichi Nomoto; Takashi Owa; Stefano Monti; Maria A Kukuruzinska; Catherine E Costello Journal: Mol Omics Date: 2020-03-23
Authors: Eduardo Castro-Nallar; Ying Shen; Robert J Freishtat; Marcos Pérez-Losada; Solaiappan Manimaran; Gang Liu; W Evan Johnson; Keith A Crandall Journal: BMC Med Genomics Date: 2015-08-16 Impact factor: 3.063
Authors: Samuel W Brady; Jasmine A McQuerry; Yi Qiao; Stephen R Piccolo; Gajendra Shrestha; David F Jenkins; Ryan M Layer; Brent S Pedersen; Ryan H Miller; Amanda Esch; Sara R Selitsky; Joel S Parker; Layla A Anderson; Brian K Dalley; Rachel E Factor; Chakravarthy B Reddy; Jonathan P Boltax; Dean Y Li; Philip J Moos; Joe W Gray; Laura M Heiser; Saundra S Buys; Adam L Cohen; W Evan Johnson; Aaron R Quinlan; Gabor Marth; Theresa L Werner; Andrea H Bild Journal: Nat Commun Date: 2017-11-01 Impact factor: 14.919
Authors: Mumtahena Rahman; Shelley M MacNeil; David F Jenkins; Gajendra Shrestha; Sydney R Wyatt; Jasmine A McQuerry; Stephen R Piccolo; Laura M Heiser; Joe W Gray; W Evan Johnson; Andrea H Bild Journal: Genome Med Date: 2017-04-26 Impact factor: 11.117
Authors: Vinay K Kartha; Khalid A Alamoud; Khikmet Sadykov; Bach-Cuc Nguyen; Fabrice Laroche; Hui Feng; Jina Lee; Sara I Pai; Xaralabos Varelas; Ann Marie Egloff; Jennifer E Snyder-Cappione; Anna C Belkina; Manish V Bais; Stefano Monti; Maria A Kukuruzinska Journal: Genome Med Date: 2018-07-20 Impact factor: 11.117
Authors: Carole L Yauk; Julie K Buick; Andrew Williams; Carol D Swartz; Leslie Recio; Heng-Hong Li; Albert J Fornace; Errol M Thomson; Jiri Aubrecht Journal: Environ Mol Mutagen Date: 2016-03-04 Impact factor: 3.216